· Periodic Report
Q3 revenue KRW 7.2 billion, loss from main business KRW 7.5 billion
Genome & Company sold KRW 7.2 billion in Q3 and lost KRW 7.5 billion from its main business; sales rose 10.4% from a year earlier and 15.8% from the prior quarter.
314130 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Genome & Company sold KRW 7.2 billion in Q3 and lost KRW 7.5 billion from its main business; sales rose 10.4% from a year earlier and 15.8% from the prior quarter.
Get app alerts for new disclosures from Genome&Company.